112 related articles for article (PubMed ID: 20374330)
1. Reduced bone density in patients on long-term warfarin.
Rezaieyazdi Z; Falsoleiman H; Khajehdaluee M; Saghafi M; Mokhtari-Amirmajdi E
Int J Rheum Dis; 2009 Jul; 12(2):130-5. PubMed ID: 20374330
[TBL] [Abstract][Full Text] [Related]
2. Reduced bone density in children on long-term warfarin.
Barnes C; Newall F; Ignjatovic V; Wong P; Cameron F; Jones G; Monagle P
Pediatr Res; 2005 Apr; 57(4):578-81. PubMed ID: 15695604
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys.
Binkley N; Krueger D; Engelke J; Suttie J
J Bone Miner Res; 2007 May; 22(5):695-700. PubMed ID: 17295605
[TBL] [Abstract][Full Text] [Related]
4. Decreased axial and peripheral bone density in patients taking long-term warfarin.
Philip WJ; Martin JC; Richardson JM; Reid DM; Webster J; Douglas AS
QJM; 1995 Sep; 88(9):635-40. PubMed ID: 7583077
[TBL] [Abstract][Full Text] [Related]
5. Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
Avila ML; Pullenayegum E; Williams S; Shammas A; Stimec J; Sochett E; Marr K; Brandão LR
Osteoporos Int; 2016 Apr; 27(4):1547-1557. PubMed ID: 26572757
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in patients given oral vitamin K antagonists.
Lafforgue P; Daver L; Monties JR; Chagnaud C; de Boissezon MC; Acquaviva PC
Rev Rhum Engl Ed; 1997 Apr; 64(4):249-54. PubMed ID: 9178397
[TBL] [Abstract][Full Text] [Related]
7. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease.
Donovan DS; Papadopoulos A; Staron RB; Addesso V; Schulman L; McGregor C; Cosman F; Lindsay RL; Shane E
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1892-9. PubMed ID: 9620924
[TBL] [Abstract][Full Text] [Related]
8. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation.
Sato Y; Honda Y; Kunoh H; Oizumi K
Stroke; 1997 Dec; 28(12):2390-4. PubMed ID: 9412619
[TBL] [Abstract][Full Text] [Related]
9. The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study.
Douketis JD; Ginsberg JS; Burrows RF; Duku EK; Webber CE; Brill-Edwards P
Thromb Haemost; 1996 Feb; 75(2):254-7. PubMed ID: 8815571
[TBL] [Abstract][Full Text] [Related]
10. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
Pearson DA
Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
[TBL] [Abstract][Full Text] [Related]
11. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats.
Haffa A; Krueger D; Bruner J; Engelke J; Gundberg C; Akhter M; Binkley N
J Bone Miner Res; 2000 May; 15(5):872-8. PubMed ID: 10804016
[TBL] [Abstract][Full Text] [Related]
12. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
Nguyen TV; Sambrook PN; Eisman JA
J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
[TBL] [Abstract][Full Text] [Related]
13. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.
Avgeri M; Papadopoulou A; Platokouki H; Douros K; Rammos S; Nicolaidou P; Aronis S
J Pediatr Hematol Oncol; 2008 Aug; 30(8):592-7. PubMed ID: 18799935
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
Panico A; Lupoli GA; Fonderico F; Marciello F; Martinelli A; Assante R; Lupoli G
Thyroid; 2009 May; 19(5):437-42. PubMed ID: 19415993
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
Florkowski CM; Brownlie BE; Elliot JR; Ayling EM; Turner JG
N Z Med J; 1993 Oct; 106(966):443-4. PubMed ID: 8233173
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry.
El-Desouki MI; Sherafzal MS; Othman SA
Saudi Med J; 2005 Sep; 26(9):1346-50. PubMed ID: 16155646
[TBL] [Abstract][Full Text] [Related]
17. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.
Targownik LE; Lix LM; Leung S; Leslie WD
Gastroenterology; 2010 Mar; 138(3):896-904. PubMed ID: 19931262
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
19. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
20. Single-point assessment of warfarin use and risk of osteoporosis in elderly men.
Woo C; Chang LL; Ewing SK; Bauer DC;
J Am Geriatr Soc; 2008 Jul; 56(7):1171-6. PubMed ID: 18547361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
